Skip to main content

Safety of GLP-1 agonists and other second-line diabetes meds in early pregnancy

First large study of the teratogenic risk of second-line diabetes meds in early pregnancy provides preliminary reassurance of their safety.

Register for free access or login.

Canadian Healthcare Network is an independent online community for Canadian healthcare professionals in medicine and pharmacy. It is the online home of the Medical Post and Pharmacy Practice + Business.

Membership is free and allows doctors, pharmacists, nurses and many others to get the latest breaking news, updates on clinical guidelines and read (and even write) commentary from your healthcare peers.

X
This ad will auto-close in 10 seconds